Human IgG1 broadly neutralizing monoclonal antibody with an LS Fc mutation to extend half-life; binds the HIV-1 Env gp120 CD4 binding site to neutralize virions and block attachment/entry into CD4+ T cells. Its Fc region can engage Fc gamma receptors to mediate ADCC/ADCP, aiding clearance of Env-expressing infected cells.